Audit Readiness for Investigational Product Documentation in Clinical Trials
Audit Readiness for Investigational Product Documentation in Clinical Trials How to Ensure Audit Readiness for Investigational Product Documentation Audits and inspections are inevitable in clinical trials, and investigational product (IP) documentation is often under the spotlight. Regulatory authorities such as the USFDA, EMA, and CDSCO expect comprehensive, accurate, and timely IP documentation. This tutorial provides…
Read More “Audit Readiness for Investigational Product Documentation in Clinical Trials” »